Abstract
Nintedanib (Ofev) is the first drug approved for the treatment of SSc-ILD, a rare interstitial lung disease associated with systemic sclerosis or scle......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
